PROTAGENIC THERAPEUTICS INC (PTIX) Stock Balance Sheet
NASDAQ:PTIX - Nasdaq - US74365N2027 - Common Stock - Currency: USD
| MRQ (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | 873.00K | 1.84M | 1.29M | 220.00K | 540.00K | |||
| Cash Equivalents | N/A | N/A | N/A | N/A | N/A | |||
| Marketable Securities | N/A | 0.00 | 2.77M | 7.76M | 9.83M | |||
| Other Current Assets | 55.20K | 44.40K | 144.00K | 60.00K | 690.00K | |||
| Total Current Assets | 928.20K | 1.88M | 4.20M | 8.04M | 11.06M | |||
| Non-Current Assets | ||||||||
| PPE Net | 60.50K | 73.10K | 123.30K | 0.00 | N/A | |||
| Other Non-Current Assets | N/A | N/A | N/A | N/A | N/A | |||
| Total Non-Current Assets | 60.50K | 73.00K | 123.40K | 0.00 | 0.00 | |||
| TOTAL ASSETS | 988.70K | 1.96M | 4.32M | 8.04M | 11.06M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 340.00K | 0.00 | |||
| Accrued Expenses | 165.30K | 103.00K | 113.80K | 160.00K | 280.00K | |||
| Accounts Payable | 911.70K | 839.80K | 541.50K | 620.00K | 520.00K | |||
| Other Current Liabilities | N/A | N/A | N/A | N/A | 0.00 | |||
| Total Current Liabilities | 1.08M | 942.80K | 655.30K | 1.12M | 800.00K | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 320.00K | |||
| Total Non-Current Liabilities | 0.00 | 0.00 | 0.00 | 0.00 | 320.00K | |||
| TOTAL LIABILITIES | 1.08M | 942.80K | 655.30K | 1.12M | 1.12M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -37.74M | -36.30M | -30.78M | -25.78M | -22.22M | |||
| Additional Paid In Capital | 37.78M | 37.45M | 34.56M | 33.37M | 32.41M | |||
| Minority Interest | N/A | N/A | N/A | N/A | N/A | |||
| Common Shares | 100.00 | 700.00 | 400.00 | 0.00 | 0.00 | |||
| Treasury Stock | N/A | N/A | N/A | N/A | N/A | |||
| Other Shareholders' Equity | -129.90K | -129.90K | -113.60K | -680.00K | -250.00K | |||
| Shares Outstanding | 537.60K | 517.30K | 316.80K | 308.70K | 307.30K | |||
| Tangible Book Value per Share | -0.16 | 1.96 | 11.58 | 1.60 | 2.31 | |||
| Total Shareholders' Equity | -88.30K | 1.01M | 3.67M | 6.92M | 9.94M | |||
| TOTAL LIABILITIES AND EQUITY | 988.70K | 1.96M | 4.32M | 8.04M | 11.06M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | N/A | N/A | 0.03 | |||
| Current Ratio | 0.86 | 2.00 | 6.41 | 7.18 | 13.82 | |||
| Return On Assets (ROA) | -530.09% | -282.49% | -115.66% | -44.78% | -40.69% | |||
| Return On Equity (ROE) | N/A | -545.33% | -136.32% | -52.02% | -45.27% | |||
All data in USD , ROIC based on taxRate of 0.21